Literature DB >> 23728697

Foam dressings for venous leg ulcers.

Susan O'Meara1, Marrissa Martyn-St James.   

Abstract

BACKGROUND: Venous leg ulcers are a common and recurring type of chronic or complex wound that are associated with considerable cost to patients and to healthcare providers. Primary wound contact dressings are usually applied beneath compression devices with the aim of aiding healing. Foam dressings are used frequently, and a variety of foam products is available on the market. The evidence base to guide dressing choice, however, is sparse.
OBJECTIVES: To determine the effects of foam dressings on the healing of venous leg ulcers. SEARCH
METHODS: In October 2012 we searched The Cochrane Wounds Group Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); the Database of Abstracts of Reviews of Effects (DARE) (The Cochrane Library); the Economic Evaluation Database (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EMBASE; EBSCO CINAHL. There were no restrictions based on language or date of publication. SELECTION CRITERIA: We included published or unpublished randomised controlled trials (RCTs) that evaluated the effects of any type of foam dressing in the treatment of venous ulcers. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, data extraction and risk of bias assessment. Meta-analysis was undertaken when deemed feasible and appropriate. MAIN
RESULTS: Twelve RCTs (1023 participants) reporting 14 comparisons were included in this review. There was no difference in healing outcomes between hydrocellular foam dressings and polyurethane foam dressings (three RCTs). Pooled data across five RCTs (418 participants) showed no statistically significant difference between foam dressings and hydrocolloid dressings in the proportion of ulcers healed at 12 to 16 weeks (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.81 to 1.22). No statistically significant between-group differences in healing outcomes were detected when foam dressings were compared with: paraffin gauze (two RCTs); hydrocapillary dressing (one RCT); knitted viscose dressing (one RCT); and protease modulating matrix (one RCT). No statistically significant between-group differences in the proportion of participants experiencing adverse events were detected when hydrocellular foam dressings were compared with polyurethane foam dressings, or when foam dressings were compared with hydrocapillary, hydrocolloid, or knitted viscose dressings (one RCT for each comparison). Six RCTs were considered as being at overall high risk of bias, and the remaining six RCTs were considered to be at overall unclear risk of bias. No included RCT had an overall low risk of bias. AUTHORS'
CONCLUSIONS: The current evidence base does not suggest that foam dressings are more effective in the healing of venous leg ulcers than other wound dressing treatments. The evidence in this area is of low quality. Further evidence is required from well-designed and rigorously-conducted RCTs, that employ methods to minimise bias and report them clearly, before any definitive conclusions can be made regarding the efficacy of foam dressings in the management of venous leg ulcers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728697     DOI: 10.1002/14651858.CD009907.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  15 in total

Review 1.  [Venous ulcer].

Authors:  Kornelia Böhler
Journal:  Wien Med Wochenschr       Date:  2016-07-12

2.  Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.

Authors:  Matthias Augustin; Katharina Herberger; Knut Kroeger; Karl C Muenter; Lisa Goepel; Reinhard Rychlik
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

Review 3.  Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy.

Authors:  Marta Otero-Viñas; Vincent Falanga
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-04-01       Impact factor: 4.730

4.  [Leg ulcers].

Authors:  U Wollina; L Unger; C Stelzner; J Machetanz; S Schellong
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

5.  In Vitro and Ex Vivo Analysis of Collagen Foams for Soft and Hard Tissue Regeneration.

Authors:  Ole Jung; Mike Barbeck; L U Fan; Fabian Korte; Cuifeng Zhao; Rumen Krastev; Sven Pantermehl; Xin Xiong
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.406

6.  Venous leg ulcer management in clinical practice in the UK: costs and outcomes.

Authors:  Julian F Guest; Graham W Fuller; Peter Vowden
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

Review 7.  Protease-modulating matrix treatments for healing venous leg ulcers.

Authors:  Maggie J Westby; Gill Norman; Jo C Dumville; Nikki Stubbs; Nicky Cullum
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

Review 8.  Wound Care for Venous Ulceration.

Authors:  Sarah E Schroeppel DeBacker; Julie C Bulman; Jeffrey L Weinstein
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

Review 9.  Alginate dressings for venous leg ulcers.

Authors:  Susan O'Meara; Marrissa Martyn-St James; Una J Adderley
Journal:  Cochrane Database Syst Rev       Date:  2015-08-19

10.  Dressings and topical agents for arterial leg ulcers.

Authors:  Cathryn Broderick; Fania Pagnamenta; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.